Arvind Sharma, Managing Director told Moneycontrol that the exports were done only after getting valid product permissions from the State FDA and required export no-objection certificates ...
We never sold the combination in the countries where it's banned. Our exports were done only after getting valid product permissions from the State FDA and required export NOCs,' said Arvind Sharma, ...
White Raven, a CDMO specializing in GMP formulation and aseptic fill & finish services for clinical and orphan drugs, has ...
Gattefossé, a leading provider of specialty ingredients and formulation solutions for personal care and pharmaceutical ...
2d
News Medical on MSNBIOVECTRA is honored with 2025 CDMO Leadership Award for biologicsBIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 ...
Its GMP-certified facilities provide clinical-to-commercial scale manufacturing, including aseptic fill finish capabilities for injectable therapies. The company’s investment in advanced ...
HLB Group acquires ANYGEN to boost GLP-1 obesity treatment development HLB Group enhances peptide capabilities through ANYGEN ...
Tilray Craft is being introduced to address the evolving needs of patients in Germany for flower-based medical cannabis. The brand aims to offer unique flower options that are not currently available ...
New Data Highlights Superior Efficacy and Tolerability of Avextra 10/10 in Treating Chemotherapy-Induced Neuropathic PainNews ReleaseBensheim, ...
due to a decrease in the operation rate of the first factory in the third quarter of last year and delays in the re-certification of pharmaceutical manufacturing and quality control standards (GMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results